Congenica
Series BCambridge, UKApr 2017
Congenica closed a Series B round (amount undisclosed) in Apr 2017. The company is based in Cambridge, UK. Investors in the round: BGI Genomics (BGI), Future Planet Capital, Healthlink Capital (Healthlink). Data as of Nov 2026.
Amount raised
—
undisclosed
Native amount
—
Stage
Series B
series b
Investors
3
Provenance & confidence
UnverifiedAmount
Amount undisclosed or unconverted.
Unverified
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
3 namedDate
Apr 2017
Round type
series b
Amount (EUR)
—